Literature DB >> 24263961

Platelet secretion defect in a patient with stromal interaction molecule 1 deficiency.

Lea Nakamura1, Kirstin Sandrock-Lang, Carsten Speckmann, Thomas Vraetz, Martina Bührlen, Stephan Ehl, Johan W M Heemskerk, Barbara Zieger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24263961     DOI: 10.1182/blood-2013-08-522037

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Store-operated calcium entry: Mechanisms and modulation.

Authors:  Patrick G Hogan; Anjana Rao
Journal:  Biochem Biophys Res Commun       Date:  2015-04-24       Impact factor: 3.575

2.  Systems modeling of Ca(2+) homeostasis and mobilization in platelets mediated by IP3 and store-operated Ca(2+) entry.

Authors:  Andrew T Dolan; Scott L Diamond
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

Review 3.  Diseases caused by mutations in ORAI1 and STIM1.

Authors:  Rodrigo S Lacruz; Stefan Feske
Journal:  Ann N Y Acad Sci       Date:  2015-10-15       Impact factor: 5.691

Review 4.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

Review 5.  CRACking the Molecular Regulatory Mechanism of SOCE during Platelet Activation in Thrombo-Occlusive Diseases.

Authors:  Patrick Münzer; Oliver Borst
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

6.  Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies.

Authors:  Magdolna Nagy; Tom G Mastenbroek; Nadine J A Mattheij; Susanne de Witt; Kenneth J Clemetson; Janbernd Kirschner; Ansgar S Schulz; Thomas Vraetz; Carsten Speckmann; Attila Braun; Judith M E M Cosemans; Barbara Zieger; Johan W M Heemskerk
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.